IMPOSSIBLE_LABS_LIMITED - Accounts
IMPOSSIBLE_LABS_LIMITED - Accounts
The directors present the strategic report for the Group for year ended 31 March 2022.
Fair review of the business
Although the Group witnessed a decrease in overall turnover from the previous year, this decline can largely be attributed to weakened sales in our consumer products division. Conversely, our consulting arm exhibited a strong performance, boosting its sales by 24%. This mixed financial landscape stems from management's calculated selectivity in tendering and accepting contracts, particularly in the face of unfavorable market conditions for consumer goods. Despite multiple challenges—ranging from intense competition and global COVID-19 disruptions to Brexit and Sino-American trade tensions—the Group has not only maintained a stable trading performance but also successfully secured new tenders for the forthcoming fiscal periods.
During the year, the Group's gross profit margin decreased to 53% (2021 59%). This was mainly due to the decline in consumer goods sales due to adverse market conditions. The directors and the management team continually review pricing, costing, and the management of projects to improve costing models. This puts the Group in a strong position to maximize its gross profit and manage cost mitigation in current and subsequent years.
Over the course of the year, the Group observed a contraction in its gross profit margin, falling from 59% in 2021 to 46.5%. This downturn was primarily driven by diminishing sales in the consumer goods sector, a consequence of challenging market conditions. Nevertheless, the directorial and management teams remain committed to ongoing evaluations of pricing strategies, cost structures, and project management methodologies. This proactive approach strategically positions the Group to optimize its gross profit and effectively control costs, both in the present and in future fiscal years.
While the Group has successfully reduced overhead costs relative to the previous year, these expenses remain elevated. This discrepancy arises primarily because the decline in consumer goods sales has outpaced the corresponding reduction in sector-specific overheads. Despite this challenge, the leadership team—including both directors and management—has diligently overseen and trimmed overheads wherever feasible. Concurrently, the Group remains committed to strategic investments in human capital, operational procedures, and information technology, all aimed at securing profitable contracts in the coming fiscal years..
The working capital of the Group continues to improve. The Group’s net current assets increased by $505k from $10.2m in 2021 to $10.7m in 2022. This has been achieved mainly by way of its trading activities, good management control of cash flow which has enabled the Group to pay the trade creditors quicker than previous year. The Group’s cash balance increased by $1.21m to $7.90m compared to $6.69m in 2021.
.
For further financial review of the business please see the Group Profit and loss account and Balance sheet on page 11 and 13 respectively.
The Group recognizes that its primary vulnerabilities lie in market downturns and evolving technology within the industry. A deliberate transition toward choosing contracts that pose lower risks to the Group has been initiated, a move essential for its mid-to-long-term sustainability.
Financial Risk
The board of directors has recognized the Group's principal financial hazard to be the ongoing economic disruptions arising from the Covid-19 pandemic. Mitigation strategies for this risk have been adeptly executed, as elaborated in our preceding section on the Group's approach to navigating Covid-19 challenges.
Reputational Risk
The directors note there is a continuing reputational risk to the company arising from claims from customers and these are swiftly responded to as and when received and settled where found to be necessary. The company then records these and the follow up procedures to mitigate the occurrence of future claims.
Economic Risk
The board of directors understands the critical role that strong relationships with primary clients play in detecting early indicators of financial issues. The team routinely examines sales patterns in significant markets to ensure prompt intervention should sales begin to wane. Moreover, contracts undergo ongoing evaluation, both throughout their duration and on a cumulative basis, while maintaining open channels of communication with key customers to reduce the likelihood of disagreements.
Safety
The board and staff of the Group are steadfastly committed to safety, which remains a perpetual focus. Although the Group's operations are inherently low-risk, its status as a Bcorp compels regular oversight of health, safety, and environmental practices via key management meetings. Periodic third-party reviews ensure compliance, and all team members receive thorough, ongoing training.
People
The Group relies on a skilled and motivated key executive team and workforce. The Group offers excellent training and development to drive and maintain high standards. The Group's investment in its team is critical to the continued success of the Group.
.
The Group's key financial performance indicators during the year were as follows:
| Unit | 2022 | 2021 |
Turnover | $ | 16,506,830 | 23,439.042 |
Gross profit | % | 53% | 59% |
Administrative expenses | $ | 7,655,745 | 9,107,279 |
Profit before taxation | $ | 959,273 | 4,607,252 |
Net current assets | $ | 10,527,431 | 10,121,464 |
As explained in the Fair review of the business section of this report, the Group's gross profit margin decreased to 53% (2021 59%). This was mainly due to the decline in consumer goods sales due to adverse market conditions.
Post reporting date events
The timeline of the Covid-19 pandemic and its impact in the world are detailed in Events after the reporting date note 25.
Based on the performance and outlook since the fiscal year's close, the turnover and gross profit margin have both fallen short of projections. Management's efforts to optimize the supply of materials and labor have been challenged by ongoing global complications from the Covid-19 pandemic and disruptions in the supply chain, Sino-American trade tensions and Russia-Ukraine war. The board anticipates a continued decline in profitability for 2023, due to significant investments in new product lines, with a recovery not expected until the fiscal year 2024.
While the board recognizes that the Group's robust order book, esteemed reputation, and skilled labor force—backed by effective leadership—offer a stable basis for future business expansion, they also anticipate ongoing challenges in the consumer goods sector that could jeopardize positive financial outcomes. New contracts have been acquired in the consulting business units, supplementing existing agreements. To navigate these complexities, the executive team plans to maintain their rigorous and judicious approach to selecting contracts and managing costs.
Future developments
The Group has leveraged its innovative capacities and integration of emerging technologies and methodologies throughout the Covid-19 pandemic to ensure worker safety, operational continuity, and the timely completion of customer projects. This has been facilitated by the board and management team, who have restructured and adapted operational procedures to align with social distancing and sanitation guidelines.
Committed to ongoing innovation, the Group consistently invests in the R&D of cutting-edge construction methods and technologies. The focus remains on enhancing safety measures, optimizing project timelines, integrating new materials and operational techniques, improving energy efficiency, and advancing information modeling capabilities.
Impact of War in Ukraine and Russia
The recent conflict in Ukraine has had repercussions on the Group, despite the absence of direct consulting or consumer sales to Russian markets. Surges in commodity and energy costs are propelling inflation, which in turn is pushing our pricing higher. This scenario is anticipated to adversely affect both our consulting and direct-to-consumer sectors. To counteract these effects, the board plans to intensify business development initiatives, implement pre-sales strategies, and allocate resources to additional market research for optimal product placement and continue a cost optimization strategy.
On behalf of the board
The directors present their annual report and financial statements for the year ended 31 March 2022.
The results for the year are set out on page 10.
No ordinary dividends were paid. The directors do not recommend payment of a further dividend.
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
The group's policy is to consult and discuss with employees, through staff councils and at meetings, matters likely to affect employees' interests.
Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the group's performance.
Post reporting date events are described in detail in Post reporting date events section in the Strategic Report.
In accordance with the company's articles, a resolution proposing that Sobell Rhodes LLP be reappointed as auditor of the group will be put at a General Meeting.
select suitable accounting policies and then apply them consistently; make judgements and accounting estimates that are reasonable and prudent; state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the ; prepare the on the going concern basis unless it is inappropriate to presume that the group and company will continue in business.
We have audited the financial statements of Impossible Labs Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2022 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows, the company statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2022 and of the group's profit for the year then ended; have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for Disclaimer of Opinion
We identified in the prior year that there were recorded sales in a subsidiary company, for which goods were delivered during the year ended 31 March 2022. The group was unable to determine the extent of such sales recorded in the prior year for which the subsidiary delivered the goods during the year ended 31 March 2022. We were not able to satisfy ourselves by other alternative means as to the effect of the potential adjustments that might have been found necessary with respect to the elements making up the group statement of comprehensive income, the group statement of changes in equity and the group statement of cash flows.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
We enquired of Management to obtain an understanding of the legal and regulatory frameworks that are applicable to the company and the group. The most significant that are relevant to the company and group are Data protection, Health and safety regulations, United Kingdom Generally Accepted Accounting Practice, the Companies Act 2006 and the tax legislation in respect of corporation tax, VAT and PAYE. We understood how the company and group complies with these through enquiries of management and asked of any instances of non-compliance in these areas.
We assessed the susceptibility of the company and group’s financial statements to material misstatements, including how fraud might occur through enquiries of management and to understand where they considered there was susceptibility to fraud. We obtained an understanding of the controls that the company and group has established to address the risk that prevents, deter, and detect fraud.
We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including the risks of override of controls).
We considered the programmes and controls that the company and the group has established to address risks identified, or that otherwise prevent, deter, and detect fraud, and how senior management monitors those programmes and controls. Where the risk was considered to be higher, we performed audit procedures to address each identified fraud risk.
Based on this understanding we designed our audit procedures to detect irregularities including fraud which primarily consisted of the following:
Identifying and testing of journal entries including large and unusual transactions to understand their rationale to review any instances of management override.
For management override relating to revenue recognition we obtained an understanding of the control environment relating to sales, the accounting systems and also enquired with those charged with governance on instances any known fraud.
Enquiries of management and those charged with governance on instances any known fraud around actual and potential litigation claims and/or breaches in regulations.
Obtained detailed understanding of procedures performed around the Coronavirus Job Retention Scheme claims and performed substantive procedures to ensure that such claims were reasonable and in compliance with the regulations.
We evaluated whether the company and group's COVID-19 working environment, especially remote working, may increase the inherent risk of fraud and potential rise for incentives and pressures for fraudulent claim of government support schemes.
Enquiries of the tax engagement team that are independent of the audit team for instances of non-compliance.
The senior statutory auditor reviewed the experience and expertise of the audit engagement team to ensure that they had the appropriate competence and capabilities to identify any instances of fraud and non-compliance with the relevant laws and regulations.
The objective of our audit, in respect to fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risk of material misstatement due to fraud, through designing and implementing appropriate responses; and to respond appropriately to fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and management.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Other matters which we are required to address
Comparative information in the financial statements is derived from the group's prior period financial statements which were not audited.
Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.
As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was $131,015 (2021 - $404,823 profit).
Impossible Labs Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is .
The group consists of Impossible Labs Limited and all of its subsidiaries.
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in US dollars which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest $.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.
The consolidated group financial statements consist of the financial statements of the parent company Impossible Labs Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.
All financial statements are made up to 31 March 2022. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
Entities in which the group holds an interest and which are jointly controlled by the group and one or more other venturers under a contractual arrangement are treated as joint ventures. Entities other than subsidiary undertakings or joint ventures, in which the group has a participating interest and over whose operating and financial policies the group exercises a significant influence, are treated as associates.
Investments in joint ventures and associates are carried in the group balance sheet at cost plus post-acquisition changes in the group’s share of the net assets of the entity, less any impairment in value. The carrying values of investments in joint ventures and associates include acquired goodwill.
If the group’s share of losses in a joint venture or associate equals or exceeds its investment in the joint venture or associate, the group does not recognise further losses unless it has incurred obligations to do so or has made payments on behalf of the joint venture or associate.
Unrealised gains arising from transactions with joint ventures and associates are eliminated to the extent of the group’s interest in the entity.
At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The group considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Investments in associates are initially recognised at the transaction price (including transaction costs) and are subsequently adjusted to reflect the group’s share of the profit or loss, other comprehensive income and equity of the associate using the equity method. Any difference between the cost of acquisition and the share of the fair value of the net identifiable assets of the associate on acquisition is recognised as goodwill. Any unamortised balance of goodwill is included in the carrying value of the investment in associates.
Losses in excess of the carrying amount of an investment in an associate are recorded as a provision only when the company has incurred legal or constructive obligations or has made payments on behalf of the associate.
In the parent company financial statements, investments in associates are accounted for at cost less impairment.
Entities in which the group has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
The tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
Transactions in currencies other than US dollars are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
An analysis of the group's turnover is as follows:
The average monthly number of persons (including directors) employed by the group and company during the year was:
Their aggregate remuneration comprised:
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
Impairment tests have been carried out where appropriate and the following impairment losses have been recognised in profit or loss:
The impairment losses in respect of financial assets are recognised in other gains and losses in the profit and loss account.
Details of the company's subsidiaries at 31 March 2022 are as follows:
The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:
The deferred tax asset set out above is expected to reverse within 12 months and relates to the utilisation of tax losses against future expected profits of the same period. The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
After the year end, the litigation case entered between one of the minority shareholders and the directors of the group over the rate of a proposed dividend is ongoing. The directors who are the majority shareholders have proposed to buy back the shares from all the minority shareholders.
The current state of the Covid -19 outbreak appears to be under control, the UK has been attempting to return to a more stable economic environment. However,the pandemic has been followed by the presence of higher interest rates, high inflation and uncertainty caused by the current conflict between Russia and Ukraine. The group considers the known disruptions caused by the present risks to be temporary, though it is uncertain what the full magnitude that these known disruptions will have on the economy and the company’s financial condition, liquidity and future results of operations. Management is actively monitoring the impact of the global situation on its financial condition, liquidity, operations, suppliers, industry and workforce. The group is not able to fully estimate the effects these events will have on its results of operations, financial condition or liquidity for the foreseeable future.